Clinical Trials
20 trialsNCT05187884 2026-04-23
NADOM
St Vincent's Hospital, Sydney
Phase 2 Completed
NCT05628883 2026-04-02
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT06861647 2026-04-01
iSITE
The Wellcome Sanger Institute
Completed
NCT03070392 2026-03-17
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Immunocore Ltd
Phase 2 Completed
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT02858869 2026-03-09
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Emory University
Phase 1 Completed
NCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
NCT02517736 2026-02-17
O-Mel-Sora
University Hospital, Caen
Phase 2 Completed
NCT04552223 2026-02-11
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
University of Miami
Phase 2 Completed
NCT01983748 2026-01-28
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma
University Hospital Erlangen
Phase 3 Completed
NCT04082962 2025-12-17
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Massachusetts Eye and Ear Infirmary
Phase 1 Completed
NCT01334008 2025-11-24
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
Institut Curie
Phase NA Completed
NCT01473004 2025-11-14
SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Thomas Jefferson University
Phase 2 Completed
NCT04812470 2025-09-22
HAITILS
Vastra Gotaland Region
Phase 1 Completed
NCT02849145 2025-09-19
ctDNA R0
Institut Curie
Phase NA Completed
NCT04118062 2025-09-19
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)
Institut Curie
Phase NA Completed
NCT04728113 2025-09-08
EARLY TOGETHER
Institut Curie
Phase NA Completed
NCT05004025 2025-08-15
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
HonorHealth Research Institute
Phase 1 Completed
NCT03964298 2025-08-11
imMUno
Institut Curie
Completed
NCT02874040 2025-08-08
Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
Institut Curie
Phase NA Completed